Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Non-Current Debt (2025)

CG Oncology (CGON) has disclosed Non-Current Debt for 1 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt changed N/A year-over-year to $3.0 million, compared with a TTM value of $3.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $3.0 million, changed N/A over the prior year.
  • Non-Current Debt was $3.0 million for Q4 2025 at CG Oncology, roughly flat from $3.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $3.0 million in Q3 2025 and bottomed at $3.0 million in Q3 2025.